stock poised for growth as FX headwinds ease By Investing.com
Medtronic PLC (BVMF:) (NYSE:MDT), a leading medical technology company, has been navigating a complex market environment characterized by consistent organic growth but tempered by foreign exchange headwinds. As these challenges begin to subside, analysts are increasingly optimistic about the company’s prospects for accelerating earnings growth and potential stock price appreciation.
Financial Performance and Outlook
Medtronic (NYSE:) has demonstrated resilience in its core business, maintaining organic sales growth in the 4-5% range for over a year. This consistent performance has been a bright spot for the company, even as its stock price has faced pressure due to the impact of multi-year foreign exchange hedges on earnings…
